Genocea Biosciences Inc
OTC:GNCAQ
Genocea Biosciences Inc
OTC:GNCAQ
Price:
0.0001
USD
Market Closed
Market Cap:
$5.9k
Balance Sheet
Balance Sheet Decomposition
Genocea Biosciences Inc
Genocea Biosciences Inc
Balance Sheet Decomposition is not available for
Genocea Biosciences Inc
Genocea Biosciences Inc
Balance Sheet
Genocea Biosciences Inc
Genocea Biosciences Inc
Currency: USD
| Dec-2019 | Dec-2020 | Dec-2021 | ||
|---|---|---|---|---|
| Assets | ||||
| Cash & Cash Equivalents |
40
|
80
|
37
|
|
| Cash Equivalents |
40
|
80
|
37
|
|
| Other Current Assets |
1
|
2
|
5
|
|
| Total Current Assets |
42
|
82
|
42
|
|
| PP&E Net |
9
|
14
|
13
|
|
| PP&E Gross |
9
|
14
|
13
|
|
| Accumulated Depreciation |
6
|
7
|
6
|
|
| Other Long-Term Assets |
2
|
2
|
1
|
|
| Total Assets |
53
N/A
|
98
+87%
|
56
-43%
|
|
| Liabilities | ||||
| Accounts Payable |
1
|
1
|
1
|
|
| Accrued Liabilities |
5
|
5
|
11
|
|
| Short-Term Debt |
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
15
|
5
|
|
| Other Current Liabilities |
1
|
4
|
3
|
|
| Total Current Liabilities |
6
|
25
|
19
|
|
| Long-Term Debt |
13
|
0
|
4
|
|
| Other Liabilities |
8
|
65
|
6
|
|
| Total Liabilities |
28
N/A
|
90
+225%
|
29
-68%
|
|
| Equity | ||||
| Common Stock |
1
|
0
|
0
|
|
| Retained Earnings |
331
|
375
|
408
|
|
| Additional Paid In Capital |
355
|
384
|
435
|
|
| Total Equity |
25
N/A
|
9
-64%
|
27
+201%
|
|
| Total Liabilities & Equity |
53
N/A
|
98
+87%
|
56
-43%
|
|
| Shares Outstanding | ||||
| Common Shares Outstanding |
27
|
53
|
58
|
|
| Preferred Shares Outstanding |
0
|
0
|
0
|
|
Switch to:
Switch to:
See Also
Discover More
